TAKEDA PHARMACEUTICAL (TAK) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
TAKEDA PHARMACEUTICAL insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 13 sold $13.1M of TAK stock on the open market.
Get emailed when insiders cluster-buy stocks like TAK
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TAK insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $13.1M | 20 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 TAKEDA PHARMACEUTICAL CO LTD insiders reported open-market purchases totaling $0, while 13 insiders reported sales totaling $13.1M. 2 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 15SEC | Lauren Rusckowski DupreyChief Transformation Officer | Sell | 34,535191,522 held (−15%) | $18.54 | $640K | +1.0% | — |
| Sep 3SEC | Andrew Stewart PlumpPresident | Sell Plan | 116,191145,465 held (−44%) | $18.49 | $2.1M | +1.3% | — |
| Aug 21SEC | Andrew Stewart PlumpPresident | Sell Plan | 19,651261,656 held (−7%) | $18.49 | $363K | +1.3% | — |
| Aug 19SEC | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sell | 12,98040,049 held (−24%) | $18.11 | $235K | +3.4% | — |
| Aug 12SEC | Andrew Stewart PlumpPresident | Sell | 165,393766,569 held (−18%) | $17.10 | $2.8M | +9.5% | — |
| Aug 12SEC | Julie So-young KimCEO, President | Sell | 89,090391,489 held (−19%) | $17.10 | $1.5M | +9.5% | — |
| Aug 12SEC | Teresa Marie BitettiPresident | Sell | 50,012252,010 held (−17%) | $17.10 | $855K | +9.5% | — |
| Aug 12SEC | Lauren Rusckowski DupreyChief Transformation Officer | Sell | 47,586226,057 held (−17%) | $17.10 | $814K | +9.5% | — |
| Aug 12SEC | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sell | 33,62859,803 held (−36%) | $17.51 | $589K | +7.0% | — |
| Aug 12SEC | Giles Richard PlatfordPresident | Sell | 31,083315,838 held (−9%) | $17.10 | $532K | +9.5% | — |
| Aug 12SEC | Natalie Anne Marie FurneyGeneral Counsel | Sell | 30,868204,298 held (−13%) | $17.10 | $528K | +9.5% | — |
| Aug 12SEC | Gabriele RicciChief Data & Tech. Officer | Sell | 25,088171,654 held (−13%) | $17.10 | $429K | +9.5% | — |
| Aug 12SEC | Agosti Marcello PignagnoliHead, Strat. & Port. Dev | Sell | 22,957176,977 held (−11%) | $17.10 | $393K | +9.5% | — |
| Aug 12SEC | Elaine Mary ShannonPres., Global Supply & Quality | Sell | 20,36367,311 held (−23%) | $17.55 | $357K | +6.7% | — |
| Aug 12SEC | Rhonda Janice PachecoPresident | Sell | 16,901182,507 held (−8%) | $17.10 | $289K | +9.5% | — |
| Aug 12SEC | Awny Samaan Botros FarajallahChief Medical Officer | Sell | 14,006116,177 held (−11%) | $17.10 | $240K | +9.5% | — |
| Aug 12SEC | Ramy Riad Ahmed IbrahimPresident | Sell | 7,277102,588 held (−7%) | $17.10 | $124K | +9.5% | — |
| Aug 12SEC | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sell | 6,77453,029 held (−11%) | $17.10 | $116K | +9.5% | — |
| Aug 12SEC | Elaine Mary ShannonPres., Global Supply & Quality | Sell | 3,97863,333 held (−6%) | $17.10 | $68K | +9.5% | — |
| Aug 12SEC | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sell | 97593,431 held (−1%) | $17.50 | $17K | +7.0% | — |
Insiders at TAKEDA PHARMACEUTICAL CO LTD
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Andrew Stewart PlumpPresident | — | $5.3M | Sep 3, 2026 | — |
| Julie So-young KimCEO, President | — | $1.5M | Aug 12, 2026 | — |
| Lauren Rusckowski DupreyChief Transformation Officer | — | $1.5M | Sep 15, 2026 | — |
| Nicola Deidre Petal GreenwayChief Human Resources Officer | — | $957K | Aug 19, 2026 | — |
| Teresa Marie BitettiPresident | — | $855K | Aug 12, 2026 | — |
| Giles Richard PlatfordPresident | — | $532K | Aug 12, 2026 | — |
| Natalie Anne Marie FurneyGeneral Counsel | — | $528K | Aug 12, 2026 | — |
| Gabriele RicciChief Data & Tech. Officer | — | $429K | Aug 12, 2026 | — |
| Elaine Mary ShannonPres., Global Supply & Quality | — | $425K | Aug 12, 2026 | — |
| Agosti Marcello PignagnoliHead, Strat. & Port. Dev | — | $393K | Aug 12, 2026 | — |
| Rhonda Janice PachecoPresident | — | $289K | Aug 12, 2026 | — |
| Awny Samaan Botros FarajallahChief Medical Officer | — | $240K | Aug 12, 2026 | — |
| Ramy Riad Ahmed IbrahimPresident | — | $124K | Aug 12, 2026 | — |
TAK stock: common questions
Are TAKEDA PHARMACEUTICAL CO LTD insiders buying TAK stock?
In the past 12 months, 0 insiders reported open-market purchases of TAK worth $0.
Are TAKEDA PHARMACEUTICAL CO LTD insiders selling TAK stock?
13 insiders reported sales worth $13.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TAK's 52-week range?
Over the past year TAK has traded between $13.23 and $19.05. It last closed at $18.73 on Oct 9, 2026.